BTC Health (BTC) 2018年年度报告「ASX」.pdf

1、 19 Annual Report Year ended 30th June 2018 BTC health Limited 1 Contents Chairmans Letter .2 Directors Report .3 Corporate Governance Statement .9 Financial Report.14 Directors Declaration .35 Auditors Independence Declaration .36 Independent Auditor Report .37 Shareholder Information .41 Corporate

2、 Directory .43 BTC health Limited 2 Chairmans letter Over the last year we have continued to focus on building capabilities within our investee companies that will ultimately assist us in transforming the group into a high growth and sustainable business.We have remained disciplined in the way that

3、we operate our investee companies,and at the same time remained very active in scoping and evaluating new and transformative opportunities.We are particularly interested in potential acquisitions that we believe could add significantly to our scale and long-term growth prospects.The Board maintains

4、a high level of confidence in the companys ability to identify,fund and to complete such investments,all the while ensuring that we operate within the prescribed rules of a Pooled Development Fund.Our cash position at 30 June 2018 was$2.65 million and our investment plan remains fully compliant with

5、 the requirements of being a registered Pooled Development Fund(PDF).The Board recognises the tremendous potential value that the PDF status confers and will continue to take all reasonable steps to maintain this.In April we divested our interests in the advisory firm Biointelect,given that this inv

6、estment did not deliver the anticipated outcomes and returns to the group.This re-enforced our view that shareholders interests are better served by keeping a clear focus on the in-licensing and product distribution elements of our business.In November we changed the company name to BTC health in or